|
WO2021080761A1
|
|
Lettuce with increased shelf life
|
|
WO2020092733A1
|
|
Serine recombinases mediating stable integration into plant genomes
|
|
WO2020076819A1
|
|
Cells and methods for the production of ursodeoxycholic acid and precursors thereof
|
|
WO2020018926A1
|
|
Exosome delivery of skin care peptides
|
|
WO2020014285A2
|
|
Fusion constructs and methods of using thereof
|
|
WO2019195679A1
|
|
Tilapia with enhanced growth characteristics
|
|
CN111511391A
|
|
Polypeptide compositions comprising spacer regions
|
|
WO2019075159A1
|
|
Advanced genome editing
|
|
WO2019071000A1
|
|
Microorganisms and methods for the fermentation of cannabinoids
|
|
CA3078818A1
|
|
Microorganisms and methods in the fermentation of benzylisoquinoline alkaloids
|
|
KR20200015939A
|
|
Expression of Novel Cell Tags
|
|
CN110770249A
|
|
Delivery of autologous cells comprising matrix metalloproteinases for treatment of scleroderma
|
|
AU2018235765A1
|
|
Methods and microorganisms for making 1,4-butanediol and derivatives thereof from C1 carbons
|
|
AU2018213395A1
|
|
Molecular switches
|
|
EP3568474A1
|
|
Modulating expression of polypeptides via new gene switch expression systems
|
|
KR20190090390A
|
|
Steroid administration and immunotherapy
|
|
CN110139933A
|
|
Frataxin expression construct
|
|
US2019233834A1
|
|
Control of phenotype in plants
|
|
SG11201810952PA
|
|
Lantibiotic variants and uses thereof
|
|
WO2018005553A1
|
|
Compositions and methods for making benzylisoquinoline alkaloids, morphinan alkaloids, thebaine, and derivatives thereof
|
